XML 74 R49.htm IDEA: XBRL DOCUMENT v3.20.1
Transition period (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Mar. 31, 2020
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]                        
Net sales $ 74,712 $ 80,760 $ 67,615 $ 59,764 $ 66,141 $ 78,571 $ 63,889 $ 59,055 $ 65,920 $ 282,851 $ 267,435 $ 269,888
Cost of sales         25,650       25,712 101,728 104,694 105,163
Gross profit 48,064 52,520 43,348 37,191 40,491 46,919 38,969 36,645 40,208 181,123 162,741 164,725
Selling, general, and administrative expenses         37,324       36,234 157,155 136,579 131,446
Restructuring (income) loss         22,176       0 (5,982) 0 0
Operating income (loss)         (19,009)       3,974 29,950 26,162 33,279
Other income (expense), net         (315)       (888) 426 (390) (2,035)
Interest expense, net         (1,849)       (1,963) (6,307) (7,816) (8,775)
Income (loss) before provision for income taxes         (21,173)       1,123 24,069 17,956 22,469
Income tax (provision) benefit         3,259       (433) (6,185) (2,431) 11,006
Net income (loss) $ (341) $ 8,002 $ 6,517 $ 3,706 (17,914) $ 9,672 $ 3,915 $ 1,248 690 17,884 15,525 33,475
Comprehensive income (loss)         $ (17,914)       $ 690 $ 17,884 $ 15,525 $ 33,475
Basic (in USD per share) $ (0.01) $ 0.16 $ 0.13 $ 0.08 $ (0.37) $ 0.20 $ 0.08 $ 0.03 $ 0.01 $ 0.37 $ 0.33 $ 0.74
Diluted (in USD per share) $ (0.01) $ 0.16 $ 0.13 $ 0.07 $ (0.37) $ 0.20 $ 0.08 $ 0.03 $ 0.01 $ 0.35 $ 0.32 $ 0.68
Basic (in shares)         48,022,926       46,435,560 48,498,813 46,828,798 45,358,452
Diluted (in shares)         48,022,926       49,302,771 50,817,143 49,268,616 49,374,758
Cash flows from operating activities:                        
Net income (loss) $ (341) $ 8,002 $ 6,517 $ 3,706 $ (17,914) $ 9,672 $ 3,915 $ 1,248 $ 690 $ 17,884 $ 15,525 $ 33,475
Depreciation and amortization         7,544       4,288 22,843 17,861 14,521
Restructuring (income) loss         22,176       0 (5,982) 0 0
Stock-based compensation expense         3,683       3,640 15,488 16,821 13,474
Amortization of debt issuance costs and discount on debt         190       199 747 792 810
Deferred income taxes         (3,433)       735 2,443 (939) (13,434)
Other, net         242       142 873 476 1,728
Accounts receivable         4,215       12,771 2,504 7,649 (8,001)
Inventories         2,561       951 (435) 16,338 6,718
Prepaid expenses and other assets         (1,732)       (1,498) (6,500) (8,484) (11,200)
Accounts payable and accrued expenses         (6,021)       (16,891) 5,962 (10,251) (25,483)
Other liabilities         (3,295)       3 (11,514) (206) (230)
Net cash provided by operating activities         8,216       5,030 44,313 55,582 12,378
Cash flows from investing activities:                        
Purchase of property and equipment         (3,400)       (2,667) (9,422) (8,872) (7,544)
Net cash used in investing activities         (3,400)       (2,667) (35,345) (8,872) (10,419)
Cash flows from financing activities:                        
Proceeds from revolving line of credit         0       2,000 0 2,000 25,900
Repayment of revolving line of credit         0       (2,000) 0 (2,000) (25,900)
Repayment of long-term debt         (2,063)       (2,063) (9,488) (8,250) (8,250)
Cash received from issuance of common stock         115       212 1,488 3,176 1,978
Other, net         (199)       (97) (771) (490) (404)
Net cash used in financing activities         (2,147)       (1,948) (16,675) (5,564) (7,195)
Net (decrease) increase in cash and cash equivalents         2,669       415 (7,707) 41,146 (5,236)
Cash and cash equivalents - beginning of period       $ 53,874 51,205     $ 10,474 10,059 53,874 10,059 15,295
Cash and cash equivalents - end of period $ 46,167       $ 53,874 $ 51,205     $ 10,474 $ 46,167 $ 51,205 $ 10,059